Asia Vital Components Co Ltd (3017) fair value: what the stock is really worth
As of Oct 22, 2026: fair value (intrinsic value) of Asia Vital Components Co Ltd stock TWD 2,737, price TWD 3,145, upside -13.0%, quality 74 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 22, 2026.
How to read this chart
60‑month range 64.29 TWD – 3,685 TWD · fair‑value band 2,053 TWD – 3,432 TWD · the 3,145 TWD price screens above the 2,737 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 22, 2026.
Follow Asia Vital Components Co in your weekly email
Every Wednesday you see whether Asia Vital Components Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Asia Vital Components Co., Ltd., together with its subsidiaries, provides total thermal solutions worldwide.
Show moreShow less
It is involved in the manufacturing, installation, processing, sales, and import and export of various electronic components, electronic materials, communication electronic machinery products, auto parts, lighting equipment, and computer peripherals.
The company also offers cooling products, such as DC fan, EC fan, thin centrifugal fan and fan array, active heat sink, heat pipe and vapor chamber, far-end radiator, radiator, and compressor radiator; cooling solution for computers, communication equipment, energy, cars, transportation, and other applicable field of industrial cooling; and motherboard and casing products.
In addition, it designs and manufactures PC-related system products; development and research of hinge products, as well as its structure, logical, and mechanical build; manufactures web camera modules and cellphone camera modules; and develops touch panel products, including tablet and AIO, industrial products, and LCM+TP. Further, the company provides legal solutions and assists its customers to obtain product recognitions; and systematic assembly, testing, program preload, package, and delivery services.
Asia Vital Components Co., Ltd. was incorporated in 1991 and is headquartered in Kaohsiung, Taiwan.
Stock analysis
Asia Vital Components Co Ltd (3017) currently trades at 3,145 TWD, while our model-based Fair Value estimate is 2,737 TWD, 13.0% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 1,938 TWD per share, and 0 of the 26 models we run sit above the 3,145 TWD price.
Bear case: the Economic Profit group reads lowest at 476.81 TWD, and 26 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: 2,053 TWD (bear) to 3,432 TWD (bull), the price of 3,145 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 74/100 (solid quality), in the Technology sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Asia Vital Components Co Ltd reported revenue of 140B TWD in FY2025 versus 47.3B TWD in FY2021, a compound +31.1%/yr. Reported net income was 19.2B TWD in FY2025, compounding +60.4%/yr from FY2021.
Key figures
Market cap 1.3T TWD (≈ $38.6B) Large · P/E ratio 42.6 · P/S ratio 6.80 · EPS (TTM) 73.89 TWD · Dividend yield 0.7% · Net margin 15.9% · Return on equity 66.8% · Return on assets (EBIT) 11.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 79 out of 100 (low confidence).
What moves the price
The share trades about 15% below its 52-week high and 169% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Technology peers we cover trades at −44% fair-value upside, at −13%, 3017 screens cheaper than that median.
Fair Value models
Bear2,053 TWDFair Value 2,737 TWDBull3,432 TWD
Price 3,145 TWD · Upside -13.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (43.04 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+94.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+35.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+28.6%
Start year 2020 (pandemic). Over 10 years: +18.5% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.2%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+48.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+47.3%
Dividend (yield on the price)0.7%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.53.2% vs 36.1%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.8% → 20%
2025 sits 229% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+23.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+38.9%
Yearly sales growth analysts expect, extended to five years.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +21.2% a year for the price and +36.8% for the forecasts.
Compare Asia Vital Components Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronic Components · 640 stocks
Beats the industry median on 7/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score74 · Top 25%
Fair Value upside−13.0% · Above median
Profitability
Return on equity (12 months)66.8% · Top 25%
Return on assets12.0% · Top 25%
Net margin (12 months)15.9% · Top 25%
Operating margin (12 months)27.4% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)66.0% · Top 25%
Dividend yield (12 months)0.7% · Below median
Balance sheet
Debt / equity0.16× · Above median
Valuation Multiplesvs Electronic Components median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Asia Vital Components Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/3017
Frequently asked questions
Is Asia Vital Components Co Ltd (3017) overvalued or undervalued?
As of Oct 22, 2026, our model estimates a fair value of 2,737 TWD versus a price of 3,145 TWD, about −13% upside (overvalued).
What is the fair value of 3017?
Our model-based fair value for Asia Vital Components Co Ltd is 2,737 TWD (as of Oct 22, 2026), built from audited fundamentals. The current price: 3,145 TWD.
What is the quality score of 3017?
Asia Vital Components Co Ltd has a Quality Score of 74/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Asia Vital Components Co Ltd (3017)?
Our model-based price target is the fair value of 2,737 TWD (as of Oct 22, 2026) from 26 valuation models. Cautious scenario 2,053 TWD, optimistic scenario 3,432 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Asia Vital Components Co Ltd stock forecast for 2026?
Our models put fair value at 2,737 TWD, about −13% upside versus a price of 3,145 TWD (overvalued). Cautious scenario 2,053 TWD, optimistic scenario 3,432 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Asia Vital Components Co Ltd (3017)?
Asia Vital Components Co Ltd reported trailing-twelve-month revenue of about 185B TWD (latest available figure, as of Oct 22, 2026).
Does Asia Vital Components Co Ltd pay a dividend?
Asia Vital Components Co Ltd currently shows a dividend yield of 0.67% relative to its recent price (as of Oct 22, 2026).
What growth is priced into Asia Vital Components Co Ltd (3017)?
For today's price to be fair in a discounted-cash-flow model, Asia Vital Components Co Ltd would have to grow free cash flow by +23.2 % per year for five years (discount rate 9.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +28.6 % per year. As of Oct 22, 2026.
What discount rate (WACC) does the fair value of 3017 use?
Our models discount Asia Vital Components Co Ltd at 9.2 %: a base by market capitalisation (large), damped by beta 0.75, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Asia Vital Components Co Ltd that is +23.2 % per year a year over ten years, using the same discount rate (9.2 %) and the same formula as our fair value.
How much growth has Asia Vital Components Co Ltd (3017) delivered so far?
Over the past 5 years revenue at Asia Vital Components Co Ltd grew +28.6 % a year. The price currently implies +23.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Asia Vital Components Co Ltd (3017) growing?
The median revenue growth in the sector is +10.8 % a year. That is the yardstick for the growth priced into Asia Vital Components Co Ltd (+23.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Asia Vital Components Co Ltd (3017)?
The free-cash-flow yield on the price is 2.18 %: that much free cash flow Asia Vital Components Co Ltd produces per unit of market value. When it exceeds the discount rate of our models (9.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Asia Vital Components Co Ltd (3017)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Asia Vital Components Co Ltd it is 2,737 TWD per share (as of Oct 22, 2026), against a price of 3,145 TWD. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Asia Vital Components Co Ltd stock overvalued or undervalued in 2026?
As of Oct 22, 2026, 3017 trades above its calculated fair value: price 3,145 TWD, fair value 2,737 TWD, a gap of about −13% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 3017?
No. The price is what the market pays today (3,145 TWD); the fair value is what the company's own numbers justify (2,737 TWD). For Asia Vital Components Co Ltd the two are 407.86 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Asia Vital Components Co Ltd worth?
The market values Asia Vital Components Co Ltd at about 1.3T TWD (market capitalisation, as of Oct 22, 2026). Per share that is 3,145 TWD; our models calculate a fair value of 2,737 TWD per share.
What do the bullish and bearish scenarios say about 3017?
Our models span a range for Asia Vital Components Co Ltd: cautious scenario 2,053 TWD, base 2,737 TWD, optimistic 3,432 TWD per share (as of Oct 22, 2026, price 3,145 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 3017?
Asia Vital Components Co Ltd trades at a price-to-earnings ratio of 42.6 (as of Oct 22, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 2,737 TWD is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 13.1. Other multiples: P/B 28.2, P/S 6.8, EV/EBITDA 25.7.
How solid is the balance sheet of Asia Vital Components Co Ltd (3017)?
Balance-sheet figures for Asia Vital Components Co Ltd (as of Oct 22, 2026): return on equity 66.8%, debt of 0.16 per unit of equity. They feed the Quality Score of 74/100, which measures business quality independently of the share price.
How far is 3017 from its 52-week high?
Asia Vital Components Co Ltd trades at 3,145 TWD, about 15% below its 52-week high of 3,685 TWD and 169% above the low of 1,170 TWD (as of Oct 22, 2026). Distance from the high says nothing about value: that is what the fair value of 2,737 TWD is for.
Which stocks are comparable to Asia Vital Components Co Ltd?
From the same area (Technology) we also value Amphenol Corporation, Delta Electronics, Inc, Corning Incorporated, Samsung Electro-Mechanics Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Asia Vital Components Co Ltd stock attractive at the current price?
The data as of Oct 22, 2026: price 3,145 TWD, calculated fair value 2,737 TWD (−13%), Quality Score 74/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 3017 calculated?
We run Asia Vital Components Co Ltd through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 2,737 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3 % above its aggregate fair value. Asia Vital Components Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Asia Vital Components Co Ltd (3017)?
The closing price on Oct 22, 2026 was 3,145 TWD. Our model-based fair value is 2,737 TWD, about −13% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Asia Vital Components Co Ltd right now?
The price sits in the upper half of our model range, so the margin of safety is thin. The data supports the verdict: every model runs on fully documented inputs.
Where does the earnings growth of Asia Vital Components Co Ltd (3017) come from?
Earnings per share at Asia Vital Components Co Ltd grew +32.4 % a year from 2014 to 2025. Broken into its drivers: revenue per share +13.7 %, EBIT margin +17.3 %, tax rate −0.1 %, residual (interest, one-offs) −0.6 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Asia Vital Components Co Ltd
How large is the market capitalisation of Asia Vital Components Co Ltd (3017)?
The market capitalisation of Asia Vital Components Co Ltd is 1.3T TWD (≈ $38.6B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Asia Vital Components Co Ltd (3017)?
The price-to-sales ratio of Asia Vital Components Co Ltd is 6.80 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Asia Vital Components Co Ltd (3017)?
Earnings per share at Asia Vital Components Co Ltd are 73.89 TWD (price ÷ EPS = P/E 42.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Asia Vital Components Co Ltd (3017)?
The dividend yield of Asia Vital Components Co Ltd is 0.7% (payout 28.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Asia Vital Components Co Ltd (3017)?
The net margin of Asia Vital Components Co Ltd is 15.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Asia Vital Components Co Ltd (3017)?
The return on equity (ROE) of Asia Vital Components Co Ltd is 66.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Asia Vital Components Co Ltd (3017)?
On an EBIT basis the return on assets of Asia Vital Components Co Ltd is 11.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Asia Vital Components Co Ltd (3017)?
The operating margin of Asia Vital Components Co Ltd is 27.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Asia Vital Components Co Ltd (3017)?
Revenue at Asia Vital Components Co Ltd is growing +66.0% versus a year earlier (3y avg +35.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Asia Vital Components Co Ltd (3017)?
Earnings per share at Asia Vital Components Co Ltd are growing +139% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Asia Vital Components Co Ltd (3017) hold?
Asia Vital Components Co Ltd holds more cash than debt, 25.3B TWD net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Asia Vital Components Co Ltd in the live analysis
One click puts Asia Vital Components Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Broad data
Oct 22, 2026